UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

JNCI : Journal of the National Cancer Institute, 2005-06, Vol.97 (12), p.880-887

2005

Volltextzugriff (PDF)

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.825-830

2007

Volltextzugriff (PDF)

Temozolomide in the treatment of recurrent malignant glioma

Cancer, 2004-02, Vol.100 (3), p.605-611

2004

Volltextzugriff (PDF)

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme

International journal of radiation oncology, biology, physics, 1998-01, Vol.40 (2), p.287-295

1998

Volltextzugriff (PDF)

Survival and functional status after resection of recurrent glioblastoma multiforme

Neurosurgery, 1998-04, Vol.42 (4), p.709-719

1998

Volltextzugriff (PDF)

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

Neuro-oncology (Charlottesville, Va.), 2006-01, Vol.8 (1), p.67

2006

Volltextzugriff (PDF)

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost

International journal of radiation oncology, biology, physics, 1994-07, Vol.29 (4), p.719-727

1994

Volltextzugriff (PDF)

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

International journal of radiation oncology, biology, physics, 2004-10, Vol.60 (2), p.353-357

2004

Volltextzugriff (PDF)

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma

International journal of radiation oncology, biology, physics, 2005-04, Vol.61 (5), p.1454-1459

2005

Volltextzugriff (PDF)

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

International journal of radiation oncology, biology, physics, 2001, Vol.49 (1), p.71-77

2001

Volltextzugriff (PDF)

Radiation response and survival time in patients with glioblastoma multiforme

Journal of neurosurgery, 1996-03, Vol.84 (3), p.442

1996

Volltextzugriff (PDF)

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy forNewlyDiagnosed Glioblastoma Multiforme

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.825-830

2007

Volltextzugriff (PDF)

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2188-2194

1998

Volltextzugriff (PDF)

Long-Term Survival in Patients with Glioblastoma Multiforme

Neurosurgery, 1993-05, Vol.32 (5), p.716-720

1993

Volltextzugriff (PDF)

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

Neuro-oncology (Charlottesville, Va.), 2006-01, Vol.8 (1), p.67-78

2006

Volltextzugriff (PDF)

High activity iodine-125 interstitial implant for gliomas

International journal of radiation oncology, biology, physics, 1992, Vol.24 (4), p.583-591

1992

Volltextzugriff (PDF)

Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme

International journal of radiation oncology, biology, physics, 1996-04, Vol.35 (1), p.37-44

1996

Volltextzugriff (PDF)

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

Journal of neuro-oncology, 1994-01, Vol.19 (1), p.69-74

1994

Volltextzugriff (PDF)

Radiation Therapy and Hydroxyurea Followed by the Combination of 6-Thioguanine and BCNU for the Treatment of Primary Malignant Brain Tumors

International journal of radiation oncology, biology, physics, 1998, Vol.40 (1), p.57-63

1998

Volltextzugriff (PDF)

Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience

International journal of radiation oncology, biology, physics, 1992, Vol.24 (4), p.593-597

1992

Volltextzugriff (PDF)

Proliferative potential and prognostic evaluation of low-grade astrocytomas

Journal of neuro-oncology, 1994-01, Vol.19 (1), p.1-9

1994

Volltextzugriff (PDF)

Treatment of Recurrent Gliomas With Eflornithine

JNCI : Journal of the National Cancer Institute, 1992-09, Vol.84 (18), p.1432-1437

1992

Volltextzugriff (PDF)

Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children

Neuro-oncology (Charlottesville, Va.), 2000-01, Vol.2 (1), p.22-28

2000

Volltextzugriff (PDF)

Intravenous carboplatin for recurrent gliomas : A dose-escalating phase II trial

American journal of clinical oncology, 1996-12, Vol.19 (6), p.609-612

1996

Volltextzugriff (PDF)

Body size, reproductive factors, and breast cancer survival

Preventive medicine, 1988-09, Vol.17 (5), p.634-642

1988

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(53)
Tagungsberichte
(14)

Sprache

Englisch
(67)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Humans
(31)
Life Sciences & Biomedicine
(30)
Adult
(28)
Female
(28)
Middle Aged
(28)
Male
(26)
Aged
(23)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Oncology
(20)
Technology
(15)
Brain Neoplasms - Radiotherapy
(14)
Engineering
(14)
Engineering, Electrical & Electronic
(14)
Combined Modality Therapy
(13)
Adolescent
(12)
Brain Neoplasms - Drug Therapy
(12)
Glioblastoma - Radiotherapy
(12)
Brain Neoplasms - Mortality
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy for Newly Diagnosed Glioblastoma Multiforme

Temozolomide in the treatment of recurrent malignant glioma

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme

Survival and functional status after resection of recurrent glioblastoma multiforme

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

Radiation response and survival time in patients with glioblastoma multiforme

Phase I Trial of Gross Total Resection, Permanent Iodine-125 Brachytherapy, and Hyperfractionated Radiotherapy forNewlyDiagnosed Glioblastoma Multiforme

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report

Long-Term Survival in Patients with Glioblastoma Multiforme

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1

High activity iodine-125 interstitial implant for gliomas

Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas

Radiation Therapy and Hydroxyurea Followed by the Combination of 6-Thioguanine and BCNU for the Treatment of Primary Malignant Brain Tumors

Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience

Proliferative potential and prognostic evaluation of low-grade astrocytomas

Treatment of Recurrent Gliomas With Eflornithine

Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children

Intravenous carboplatin for recurrent gliomas : A dose-escalating phase II trial

Body size, reproductive factors, and breast cancer survival

Suchergebnisse filtern